نتایج جستجو برای: kif5b

تعداد نتایج: 235  

Journal: :Annals of palliative medicine 2021

: ALK-positive histiocytosis is a rare malignancy which was first described in 2008 and recognized as systemic histiocytic disorder that can affect multiple organs. Less than 20 cases were reported to date, much fewer presented disseminated disease, especially with lung central nervous system (CNS) involvement. The clinical presentation, cytologic histologic features diverse prior cases. Diagno...

2017
David R. Hout Brock L. Schweitzer Kasey Lawrence Stephan W. Morris Tracy Tucker Rosetta Mazzola Rachel Skelton Frank McMahon John Handshoe Mary Lesperance Aly Karsan David L. Saltman

Patients with lung cancers harboring an activating anaplastic lymphoma kinase (ALK) rearrangement respond favorably to ALK inhibitor therapy. Fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) are validated and widely used screening tests for ALK rearrangements but both methods have limitations. The ALK RGQ RT-PCR Kit (RT-PCR) is a single tube quantitative real-time PCR as...

Journal: :Molecular pain 2015
Lan Bao

Voltage-gated sodium channels (Navs) comprise at least nine pore-forming α subunits. Of these, Nav1.6, Nav1.7, Nav1.8 and Nav1.9 are the most frequently studied in primary sensory neurons located in the dorsal root ganglion and are mainly localized to the cytoplasm. A large pool of intracellular Navs raises the possibility that changes in Nav trafficking could alter channel function. The molecu...

2014
Tatsushi Kodama Toshiyuki Tsukaguchi Hiroshi Sakamoto

Alectinib/CH5424802 is a known inhibitor of anaplastic lymphoma kinase (ALK) and is being evaluated in clinical trials for the treatment ofALK fusion–positive non–small cell lung cancer (NSCLC). Recently, someRET and ROS1 fusion genes have been implicated as driver oncogenes in NSCLC and have become molecular targets for antitumor agents. This study aims to explore additional target indications...

2017
Adriane F. Evangelista Maicon F. Zanon Adriana Cruvinel Carloni Flávia E. de Paula Mariana Andozia Morini Maressa Ferreira-Neto Iberê Cauduro Soares Jose Elias Miziara Pedro de Marchi Cristovam Scapulatempo-Neto Rui M. Reis

BACKGROUND ALK-rearranged lung cancers exhibit specific pathologic and clinical features and are responsive to anti-ALK therapies. Therefore, the detection of ALK-rearrangement is fundamental for personalized lung cancer therapy. Recently, new molecular techniques, such as NanoString nCounter, have been developed to detect ALK fusions with more accuracy and sensitivity. METHODS In the present...

2017
María M. López de Armentia María C. Gauron María I. Colombo

Staphylococcus aureus is a pathogen that causes severe infectious diseases that eventually lead to septic and toxic shock. S. aureus infection is characterized by the production of virulence factors, including enzymes and toxins. After internalization S. aureus resides in a phagosome labeled with Rab7 protein. Here, we show that S. aureus generates tubular structures marked with the small GTPas...

2015
Libing Xiang Jiajia Li Wei Jiang Xuxia Shen Wentao Yang Xiaohua Wu Huijuan Yang

Mutations in 16 targetable oncogenic genes were examined using reverse transcription polymerase chain reaction (RT-PCR) and direct sequencing in 285 Chinese cervical cancers. Their clinicopathological relevance and prognostic significance was assessed. Ninety-two nonsynonymous somatic mutations were identified in 29.8% of the cancers. The mutation rates were as follows: PIK3CA (12.3%), KRAS (5....

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید